Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Small

Showing results (931-940 of 1,203) with videos related to

Pageof 121
Sort By:
North Carolina Medical Journal|September 20, 2024
Racial and Rural-Urban Disparities in Maternal Cardiac Disease Care in North Carolina: A Call to ActionJulia M Moyett, Linda M Zambrano Guevara, Divya P Mallampati, et al.
Psychosomatic Medicine|September 7, 2023
Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell TransplantationAasha I Hoogland, Brian D Gonzalez, Jong Y Park, et al.
Journal of Neuroendocrinology|April 20, 2002
Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptorsM S Kim, C J Small, S H Russell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2012
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparisonKristin M Phillips, Javier Pinilla-Ibarz, Eduardo Sotomayor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled ComparisonBrian D Gonzalez, Heather S L Jim, Margaret Booth-Jones, et al.
Future Oncology (London, England)|August 20, 2024
Prostate-specific antigen and health-related quality of life in individuals with advanced prostate cancer treated with apalutamide: a plain language summary of the SPARTAN and TITAN studiesLawrence I Karsh, Katherine B Bevans, Fred Saad, et al.
JCO Oncology Practice|December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate CancerDaniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206Brian I Rini, Susan Halabi, Jonathan E Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancerEric J Small, Natalie Sacks, John Nemunaitis, et al.
Environmental Science & Technology|January 1, 2004
Sustainability science and engineering: the emergence of a new metadisciplineJames R Mihelcic, John C Crittenden, Mitchell J Small, et al.
Pageof 121

Showing results (931-940 of 1,203) with videos related to

Sort By:
Pageof 121
North Carolina Medical Journal|September 20, 2024
Racial and Rural-Urban Disparities in Maternal Cardiac Disease Care in North Carolina: A Call to ActionJulia M Moyett, Linda M Zambrano Guevara, Divya P Mallampati, et al.
Psychosomatic Medicine|September 7, 2023
Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell TransplantationAasha I Hoogland, Brian D Gonzalez, Jong Y Park, et al.
Journal of Neuroendocrinology|April 20, 2002
Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptorsM S Kim, C J Small, S H Russell, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2012
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparisonKristin M Phillips, Javier Pinilla-Ibarz, Eduardo Sotomayor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
Course and Predictors of Cognitive Function in Patients With Prostate Cancer Receiving Androgen-Deprivation Therapy: A Controlled ComparisonBrian D Gonzalez, Heather S L Jim, Margaret Booth-Jones, et al.
Future Oncology (London, England)|August 20, 2024
Prostate-specific antigen and health-related quality of life in individuals with advanced prostate cancer treated with apalutamide: a plain language summary of the SPARTAN and TITAN studiesLawrence I Karsh, Katherine B Bevans, Fred Saad, et al.
JCO Oncology Practice|December 21, 2021
Mobile Audio Recording Technology to Promote Informed Decision Making in Advanced Prostate CancerDaniel H Kwon, Sneha Karthikeyan, Alison Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206Brian I Rini, Susan Halabi, Jonathan E Rosenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Granulocyte macrophage colony-stimulating factor--secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancerEric J Small, Natalie Sacks, John Nemunaitis, et al.
Environmental Science & Technology|January 1, 2004
Sustainability science and engineering: the emergence of a new metadisciplineJames R Mihelcic, John C Crittenden, Mitchell J Small, et al.
Pageof 121